Guidelines for sore throat management in New Zealand

New Zealand Medical Journal

Volumn 122, Issue 1301, 2009, Pages 10-18

  Kerdemelidis, Melissa ^a   Lennon, Diana ^a   Arroll, Bruce ^a   Peat, Briar ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BENZATHINE PENICILLIN; CLINDAMYCIN; PENICILLIN V; RIFAMPICIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARDIOVASCULAR RISK; DISEASE TRANSMISSION; HIGH RISK PATIENT; HUMAN; NEW ZEALAND; PATIENT CARE; PATIENT CODING; PRACTICE GUIDELINE; RASH; RECURRENT INFECTION; RHEUMATIC FEVER; SCORING SYSTEM; STREPTOCOCCAL PHARYNGITIS; THROAT CULTURE; TONSILLECTOMY;

ANTI-BACTERIAL AGENTS; ASTHMA; COMORBIDITY; FAMILY PRACTICE; HUMANS; NEW ZEALAND; PENICILLIN V; PHARYNGITIS; PRACTICE GUIDELINES AS TOPIC; RHEUMATIC FEVER; RISK FACTORS; SEASONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 70049087910     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Environmental Science and Research Ltd. Notifiable and other disease in New Zealand Annual Report 2003. http://www.surv.esr.cri.nz/ PDF_surveillance/AnnSurvRpt/2003AnnualSurvRpt.pdf Wellington: Ministry of Health; 2003. Contract.
2. Gordis L. The Virtual Disappearance of Rheumatic Fever in the United States: Lessons in the Rise and Fall of Disease. Circulation. 1985;72:1155-62.
3. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovascular Disorders. 2005;5(11):1-9.
4. Cantanzaro F, Rea C. Prevention of rheumatic fever by treatment of streptococcal infections. II. Factors responsible for failures. New England Journal of Medicine. 1958;259(2):51-7.
5. Schwartz RH. Penicillin V for Group A Streptococcal Pharyngotonsillitis. A Randomized Trial of Seven vs Ten Days' Therapy. Journal of the American Medical Association. 1981;246(16):1790-5.
6. Gerber MA, Randolph MF, Chanatry J, et al. Five vs Ten Days of Penicillin V Therapy for Streptococcal Pharyngitis. American Journal of Diseases of Children. 1987;141:224-7.
7. Lennon D, Farrell E, Stewart J, Martin D. Once-daily Amoxicillin Versus Twice-daily Penicillin V in Group A β-Hemolytic Streptococcal Pharyngitis. Archives of Diseases in Childhood. 2008;93:474-8.
8. Feder HM Jr, Gerber MA, Randolph MF, et al. Once-Daily Therapy for Streptococcal Pharyngitis with Amoxicillin. Pediatrics. 1999;103(1):47-51.
9. Clegg HW, Dallas SD, Kaplan EL, et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatric Infectious Disease Journal. 2006;25(9):761-7.
10. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of Streptococcal Pharyngitis with Amoxycillin Once a Day. British Medical Journal. 1993;306:1170-2.
11. Cantanzaro F J, et al. The role of the streptococcus in the pathogenesis of rheumatic fever. American Journal of Medicine. 1954;17:749-56.
12. Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis (IDSA Guidelines). Clinical Infectious Diseases. 2002;35:113-25.
13. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Annals of Internal Medicine. 2001;134:509-17.
14. Committee on Infectious Diseases AAoP. Group A streptococcal infections. In: Pickering LK, et al, editor. Red Book 2006: report of the committee on infectious diseases. 27 ed. Elk Grove: American Academy of Pediatrics; 2006. p610-20.
15. McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. Journal of the American Medical Association. 2004;291(13):1587-95.
16. Bisno A. Pharyngitis. In: Mandell GL, Dolin R, editors. Mandell, Douglas & Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005A. p752-8.
17. Stuart-Harris CH, Andrews BE, Beale AJ, et al. A collaborative study of the aetiology of acute respiratory infections in Britain 1961-4: a report of the medical research council working party on acute respiratory virus infections. British Medical Journal. 1965;2:319-26.
18. Hamre D, Connelly AP Jr, Procknow JJ. Virologic studies of acute respiratory disease in young adults. IV. Virus isolations during four years of surveillance. American Journal of Epidemiology. 1966;83(2):238-49.
19. Gwaltney JMJ. Virology of middle ear. Annals of Otology, Rhinology & Laryngology. 1971;80:365-70.
20. Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh study. JAMA. 1974;227(2):164-9.
21. Armstrong GL, Pinner RW. Outpatient visits for infectious diseases in the United States, 1980 through 1996. Archives of Internal Medicine. 1999;159(21):2531-6.
22. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. [see comment]. JAMA. 2001;286(10):1181-6.
23. Shulman ST. Acute Streptococcal pharyngitis in pediatric medicine: Current issues in diagnosis and management. Pediatric Drugs. 2003;5(Suppl 1):13-23.
24. Bisno A, Stevens DL. Streptococcus Pyogenes. In: Mandell GL, Dolin R, editors. Mandell, Douglas & Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2005B. p2362-79.
25. Wannamaker L. The epidemiology of streptococcal infections. McCarty M, ed Streptococcal Infections Columbia University Press, New York. 1954.
26. Centor RM, Witherspoon JM, Dalton HP, et al. The Diagnosis of Strep Throat in Adults in the Emergency Room. Medical Decision Making. 1981;1(3):239-46.
27. Breese BB, Disney FA. Factors influencing the spread of beta hemolytic streptococcal infections within the family group. Pediatrics. 1956;17(6):834-8.
28. Linkbaek M, Hoiby EA, Lermark G, et al. Predictors for spread of clinical group A streptococcal tonsillitis within the household. Scandinavian Journal of Primary Health Care. 2004;22:239-43.
29. Falck G, Holm S, Kjellander J. The role of household contacts in the transmission of group A streptococci. Scand J Infect Dis. 1997;29:239-44.
30. Poku K. The risk of streptococcal infections in rheumatic and non- rheumatic families: an application of Greenwood's Chain - binomial model. Am J of Epidemiology. 1979;109(2):226-35.
31. Murray PR. Specimen collection, transport & processing: bacteriology. Manual of Clinical Microbiology, 8th edition, Washington: ASM Press. 2003:289-99.
32. Gerber MA, Shulman ST. Rapid Diagnosis of pharyngitis caused by Group A streptococci. Clinical Microbiology Reviews. 2004;17(3):571-80.
33. Committee on Infectious Diseases AAoP. Red Book: 2003 report of the committee on infectious diseases. 26th ed. Pickering LK, Baker CJ, Overturf GD, Prober CG, editors. Elk Grove: American Academy of Pediatrics; 2003.
34. Naparstek Y, Levy M. Rash and infectious mononucleosis. Annals of Internal Medicine. 1982;97(2):284.
35. Hardman LL. Goodman & Gillman's the Pharmacological Basis of Therapeutics. 11th edition. McGraw Hill, New York. 2006:1166-70.
36. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. British Journal of Dermatology. 2002;147:1166-70.
37. Allergy TASoCIa. Allergic Reactions to Antibiotics. Bagowlah, NSW http://wwwallergyorgau/aer/infobulletins/hp_antibioticshtm
38. Kurup V, Apter AJ (editors). Immunology and Allergy Clinics of North America, WB Saunders, Philadelphia, 1998;18,:749.
39. Ministry of Health Nga Kupu Oranga: Healthy Messages: a health and safety resource for early childhood services. 1997:1-47. http://www.moh.govt.nz/mohnsf/bytunid/ E123367969DCC12ACC256DE90078B901?Open
40. Ministry of Health infectious diseases table, HealthEd website. 2000, revised 2006:1-2. http://www.healthedgovtnz/uploads/docs/HE1214pdf
41. Pediatrics AAo. Group A streptococcal infections. In: Pickering LK, et al, editor. Red Book 2006: report of the committee on infectious diseases. 27 ed. Elk Grove: American Academy of Pediatrics; 2006. p610-20.
42. Snellman LW, Stang HJ, Stang JM, et al. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. Pediatrics. 1993;91(6):1166-70.
43. Aksit S, Caglayan S, Dokucu G. Seasonal benzathine penicillin G prophylaxis for recurrent streptococcal pharyngitis in children. Acta Paediatrica Japonica. 1998;40:256-8.
44. Mora R, Salami A, Mora F, et al. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis. International Journal of Pediatric Otorhinolaryngology. 2003;67(S1):s225-s8.
45. Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. New England Journal of Medicine. 1984;310(11):674-83.
46. Paradise JL, Bluestone CD, Colborn DK, et al. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics. 2002;110:7-15.
47. Paradise JL, Rogers KD, Taylor FH, et al. Comparative efficacy of tonsillectomy for recurrent throat infection in more versus less severely affected children. Pediatric Research. 1992;31:126A.
48. Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin Treatment of Chronic Pharyngeal Carriage of Group A Streptococci. Pediatrics. 1991;119(1 (Pt. 1)):123-8.
49. Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in Persisting Streptococcal Pharyngotonsillitis after Penicillin Treatment. Scandinavian Journal of Infectious Diseases. 1994;26:535-41.
50. Kaplan EL, Johnson DR. Eradication of Group A Streptococci from the Upper Respiratory Tract by Amoxicillin with Clavulanate after Oral Penicillin V Treatment Failure. Pediatrics. 1988;113(2):400-3.
51. Tanz RR, Shulman S, Barthel M, et al. Penicillin plus rifampin eradicates pharyngeal carriage of group a streptococci. Pediatrics. 1985;106(6):876-80.
52. Chaudhary S, Billinsky SA, Hennessy JL, et al. Penicillin V and Rifampin for the Treatment of Group A Streptococcal Pharyngitis: A randomized trial of 10 days Penicillin vs 10 days Penicillin with Rifampin during the Final 4 days of Therapy. Journal of Pediatrics. 1985;106(3):481-6.